Lantern Pharma Inc. at ThinkEquity Conference Transcript
I'm Ryan Starkes, Partner and Life Science Leader for Centri. Centri is a full-service accounting, valuation and advisory firm focusing on companies, assisting them navigating in the capital markets. I'm here to introduce Panna Sharma, CEO of Lantern Pharma Inc. Panna?
Thanks, Ryan. Everyone hear me okay? Great. I'm going to talk a little bit today about Lantern Pharma. We're publicly traded on NASDAQ, ticker LTRN. I want to thank ThinkEquity for inviting us and, more importantly, all of you sitting here today to hear our story and our update.
I may make forward-looking statements, I urge you guys to take a look at our disclosure found both on our website and also in our public filings. As we all know, drug development, specifically in oncology, is a very complex, time-consuming, and challenging task. Success rates are low. The costs are extremely high in the billions. But at the same time, there's thousands and thousands of trials out
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
